Invus Global Management, LLC - 30 Sep 2025 SCHEDULE 13G/A Report for vTv Therapeutics Inc. Class A Common Stock, $0.01 par value per share (VTVT)

Filing Manager
Invus Global Management, LLC
Reporting Manager
Raymond Debbane
Security
vTv Therapeutics Inc. Class A Common Stock, $0.01 par value per share
Symbol
VTVT
Shares outstanding
4,181,894 shares
Disclosed Ownership
393,098 shares
Ownership
9.4%
Form type
SCHEDULE 13G/A
Filing time
12 Nov 2025, 10:29:36 UTC
Date of event
30 Sep 2025
Previous filing
08 Sep 2025
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"Invus Global Management, LLC disclosed 9.4% ownership in vTv Therapeutics Inc. Class A Common Stock, $0.01 par value per share (VTVT) on 30 Sep 2025."

Quick Takeaways

  • Invus Global Management, LLC filed SCHEDULE 13G/A for vTv Therapeutics Inc. Class A Common Stock, $0.01 par value per share (VTVT).
  • Disclosed ownership: 9.4%.
  • Date of event: 30 Sep 2025.

What Changed

  • Previous schedule filing date: 08 Sep 2025.
  • Current filing was accepted on 12 Nov 2025, 10:29.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (8)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Invus Public Equities, L.P. 8.4% 345,926 345,926 0 /s/ Raymond Debbane Raymond Debbane, President of Invus Public Equities Advisors, LLC, its general partner
Invus Public Equities Advisors, LLC 8.4% 345,926 345,926 0 /s/ Raymond Debbane Raymond Debbane, President
Invus Global Management, LLC 8.4% 345,926 345,926 0 /s/ Raymond Debbane Raymond Debbane, President
Siren, L.L.C. 8.4% 345,926 345,926 0 /s/ Raymond Debbane Raymond Debbane, President
Avicenna Life Sci Master Fund LP 1.2% 47,172 47,172 0 /s/ Raymond Debbane Raymond Debbane, Chief Executive Officer of Avicenna Life Sci Master GP LLC, its general partner
Avicenna Life Sci Master GP LLC 1.2% 47,172 47,172 0 /s/ Raymond Debbane Raymond Debbane, Chief Executive Officer
Ulys, L.L.C. 1.2% 47,172 47,172 0 /s/ Raymond Debbane Raymond Debbane, President
Raymond Debbane 9.4% 393,098 393,098 0 /s/ Raymond Debbane Raymond Debbane

Sponsored